Location
Singapore, Asia
Cheque size
$2M - $20M
Investment Stage
Seed
Series A
Series B
Focus Areas
AI
Digital Health
Medical Devices
About Investor
Anselm Tan is an Investor at ClavystBio in Singapore, focusing on Digital Health, AI, and Medical Devices. He invests across Seed, Series A, and Series B stages, supporting healthcare innovation. His investment range is between $2M and $20M, with an average check size of around $3M. He evaluates startups applying AI and medical technology to improve healthcare delivery. He works closely with founders on product development and clinical validation. His role bridges healthcare technology and venture investment.
Similar Investors
TN
Tetsu Nakajima
Japan, Asia
$100K - $5M
Pre Seed
,Seed
,BT
Binh Tran
Vietnam, Asia
$500K - $2M
Pre Seed
,Seed
,AC
Alan Chan
Hong Kong, Asia
$100K - $5M
Pre Seed
,Seed
,JF
Jixun Foo
Singapore, Asia
$250K - $25M
Seed
,Series A
,YT
Yinglan Tan
Singapore, Asia
$100K - $5M
Seed
,Series A
,WC
William Chu
Hong Kong, Asia
$1M - $5M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.